Published summary: 2026-03-07
Where the evidence converges
Meta-analysis found schizophrenia patients who used cannabis had better cognitive performance than non-using patients, suggesting a different pathway to psychosis
Strong evidence · 26 studies
The meta-analysis included mostly cross-sectional studies. Better cognition in cannabis users could reflect selection bias (more cognitively intact people are more likely to access and use cannabis).
Meta-analysis of 20 fMRI studies found cannabis users show altered brain activation patterns, with different changes in adults (temporal/frontal regions) versus adolescents (parietal/putamen)
Strong evidence · 26 studies
The studies included used different cognitive tasks, which complicates interpretation of pooled results. The meta-analysis cannot determine whether brain changes preceded or followed cannabis use. Cro
Meta-analysis of 14 studies found young psychosis patients who currently use cannabis perform worse on IQ, verbal learning, and working memory, except for set-shifting where they excelled
Strong evidence · 26 studies
The studies used varied cognitive assessments, making direct comparison imperfect. The age range (15-45) is broad. Current cannabis use was defined differently across studies. The meta-analysis cannot
Where questions remain
Among 1,689 Egyptian men, cannabis users showed cognitive deficits compared to non-users, but the gap was smallest among illiterate, rural, and older participants
Moderate evidence · 108 studies
Cross-sectional design cannot determine whether cannabis caused the cognitive differences or whether pre-existing differences led some people to use cannabis. Only male participants were studied. The
A major 1986 pharmacological review found cannabis's greatest health concern was its impact on youth development, while finding no proven brain damage and limited physical dependence in adults
Moderate evidence · 108 studies
Reflects evidence available through the mid-1980s. Cannabis potency, usage patterns, and the volume of research have all changed dramatically. The review's reassurance about lung effects preceded mode
Animal studies showed chronic THC altered the hippocampus in rats, but required at least 3 months of exposure in young animals
Moderate evidence · 108 studies
Animal models have inherent limitations for predicting human neurotoxicity. Dose scaling between species is imprecise. The review predated the discovery of cannabinoid receptors in the hippocampus, so
Brain recordings revealed two distinct cannabis-related deficits: attentional filtering worsened with years of use, while processing speed slowed with frequency of use, suggesting different mechanisms
Moderate evidence · 108 studies
Cross-sectional design cannot establish causation. Pre-existing cognitive differences might predispose both to longer cannabis use and poorer attentional filtering. Sample size was not specified in th
Research gaps
- Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
- Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.
Key studies
Meta-analysis found about 1 in 4 people with ADHD have had cannabis use disorder in their lifetime
The nearly 3-fold elevated risk of CUD in ADHD populations suggests that cannabis screening should be routine in ADHD treatment. The high prevalence also raises questions about whether some ADHD patients are self-medicating with cannabis.
Prenatal Cannabis Linked to Preterm Birth, Low Birth Weight, and NICU Stays
This is the most comprehensive meta-analysis to date on prenatal cannabis effects. The birth outcome findings are robust, while the more nuanced cognitive finding (limited to attention/externalizing) pushes back against overly broad claims of developmental harm.
Prenatal Cannabis Exposure Linked to Higher ADHD and Autism Risk in Children
ADHD and ASD are among the most common neurodevelopmental disorders, and identifying modifiable risk factors is a public health priority. This meta-analysis provides pooled evidence that prenatal cannabis exposure may be one such factor.
Where THC acts in the brain depends on dose and how many cannabinoid receptors are present
Identifying where THC acts most strongly in the brain, and why, helps explain the wide range of cognitive effects reported by cannabis users and could inform dosing strategies for therapeutic applications.
Large meta-analysis maps how youth cannabis use changes brain activation patterns
Understanding how cannabis changes brain function in young people is critical because the adolescent brain is still developing. This meta-analysis provides the most comprehensive picture to date of where those changes occur.
Meta-analysis of 57 studies confirmed cannabis impairs driving, comparable to low blood alcohol
This is the largest meta-analysis of experimental driving studies on cannabis to date, providing definitive evidence that cannabis impairs driving performance and that the combination with alcohol is particularly dangerous.
How the research developed
Pre-2000
15 studies published. Includes 5 RCTs.
2000–2009
52 studies published. Includes 11 RCTs, 3 strong-evidence studies.
2010–2014
80 studies published. Includes 1 meta-analyses, 11 RCTs, 3 strong-evidence studies.
2015–2019
186 studies published. Includes 6 meta-analyses, 26 RCTs, 25 strong-evidence studies.
2020–present
372 studies published. Includes 9 meta-analyses, 36 RCTs, 51 strong-evidence studies.
How this summary was assembled
This consensus synthesizes 705 peer-reviewed studies: 16 meta-analyses (2%), 89 randomized controlled trials (13%), 237 observational studies (34%), 119 reviews (17%), 13 case studies (2%), 231 other study types (33%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.
These counts describe the source summary at publication. They may differ from the current library.